
zzso but not all patients experience weight gain 1 year after a breast cancer zzso clearly zzso clinically relevant groups at risk of weight gain have yet to be zzso We set out to determine the factors associated with weight gain over time in patients with invasive breast cancer during a period of predominantly zzso zzso chemotherapy and to identify groups with differing weight gain zzso Breast cancer patients zzso zzso were identified in a retrospective chart zzso zzso parameters included weight at diagnosis and 1, 2, and 3 years later, zzso body mass index zzso age, zzso and change in zzso status, as well as therapy and zzso zzso zzso models identified significant independent zzso of weight zzso zzso zzso analysis zzso was employed to divide the zzso into relevant and significant zzso In 185 identified patients, zzso models and zzso demonstrated that weight gain at 1 year was associated with younger age, zzso chemotherapy, and lower zzso Weight gain at 2 years zzso zzso zzso was greater than at year 1, and in addition to weight gain at year 1, was associated with younger age and zzso chemotherapy in zzso zzso zzso found that zzso therapy, age, and zzso were zzso zzso at 3 years were similar to those seen at 2 zzso zzso breast cancer patients treated with chemotherapy continue to gain weight 2 years after diagnosis, and this weight gain appears to be persistent at year zzso Observation beyond 1 year is needed to adequately evaluate weight gain in zzso breast cancer patients, particularly for those receiving contemporary zzso zzso 

